Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Potential Operational Risks Hindering QBT’s Path to Commercialisation - Quantum Blockchain

Nov 12, 2025 | Team Kalkine
Potential Operational Risks Hindering QBT’s Path to Commercialisation - Quantum Blockchain
Image source: shutterstock

  • QBT:LSE
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (GBX)

Quantum Blockchain Technologies PLC (LSE: QBT)

Quantum Blockchain Technologies PLC (LSE: QBT) is an investment company engaged in recognizing, investing, and acquiring companies, resources, and projects in the technology space. This Report covers the Key Recommendation Rationale, Conclusion, and Recommendation on the stock.

Key Recommendation Rationale – Sell at GBX 0.94

  • Continued Operating Losses and Absence of Revenue - Despite notable R&D progress, the company has yet to generate any operating revenue, while reporting a €1.5 million loss for the first half of 2025. This ongoing lack of income highlights the longer-than-expected path to commercialisation. Investors may view the sustained reliance on external funding as a concern, particularly in a competitive technology field where profitability timelines are uncertain.
  • Dependence on Future Partnerships for Commercial Success - QBT’s commercial prospects appear heavily dependent on successful collaborations with ASIC manufacturers and mining hardware providers. While early discussions and demonstrations are encouraging, none have yet materialised into confirmed contracts or licensing agreements. This dependence on third-party adoption poses a significant execution risk, as delays or failed negotiations could stall the company’s transition from R&D to revenue generation.
  • Weak Balance Sheet and Historical Net Liabilities - Although the company’s financial position improved slightly, it continues to show net liabilities of €4.5 million as of June 2025. This indicates a fragile balance sheet that may constrain long-term financial flexibility. Persistent negative equity and modest cash reserves (€1.7 million) suggest that further fundraising might be necessary to sustain operations and ongoing research, potentially leading to shareholder dilution.

Share Price Chart  

QBT Daily Technical Chart, Source - Refinitiv

Conclusion

Given its current trading levels, Weak Balance Sheet and Historical Net Liabilities, recent rally in the share price, relative valuation, and associated risks, it is prudent to exit the stock at the current levels. Hence, a ‘Sell’ recommendation is given on the stock at the Current Market Price of GBX 0.94 as of 12 November 2025 at 08:41 AM GMT.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 12 November 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and/or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’

Note 6: Dividend Yield may vary as per the stock price movement.


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions